FAQ · AndroShot

AndroShot More Information

Published 22 July 2025 · Updated 22 July 2025

AndroShot Plasma

AndroShot is a safe and effective procedure to improve erection quality. Blood is taken from your arm and spun in a centrifuge to isolate platelets containing growth factors. These are then injected into the penis to rejuvenate the penis, increasing the blood flow and improving the erection quality.

Procedure Overview

  • Price £950 with 0% finance available

  • Long-lasting effect up to 18 months

  • 20-minute procedure with no recovery time

  • Safe and minimal pain

  • Significant clinical benefit is possible 2-3 weeks following treatment
  • Can be combined with AndroShock Therapy

Likely Benefits

  • Increased Erection Firmness

  • Increased Sensation & Pleasure

  • Increased Circulation & Blood Flow

  • Helps with Peyronie’s Disease

  • Better Sexual Function after Prostate Cancer

Possible (but Less Likely) Benefits

  • Minor Temporary Increase in Penis Size

Although some patients have reported a modest increase in penis size following the AndroShot procedure, many have reported that the effect lasted only a few weeks.

If you require Penis Enlargement, then the Androfill dermal filler procedure is the correct treatment to book.

Please read our page dedicated to the AndroShot procedure.

Dr Gary Horn

Author: Dr Gary Horn

GMC Registered Plastic Surgeon

Androfill Clinic Director

Dr Greta Peciulyte

Medically reviewed by: Dr Greta Peciulyte

GMC Registered Urologist

Androfill Clinical Team

As featured in the press

Superdrug Online Doctor articleThe Guardian — AndrofillBBC News — AndrofillThe Sun — AndrofillDaily Mail — Androfill

Regulatory bodies & memberships

British Association of Urological Surgeons (BAUS)General Medical CouncilTop DoctorsCosmetic Redress SchemeInternational Society of Aesthetic Plastic SurgeryPhalloboards Approved Practitioner — Verified 2026, Trusted for Efficacy

This website is for Androfill United Kingdom

Click below for Australia, Belgium, Canada, India, Israel, New Zealand, the Philippines, Saudi Arabia, Sweden, Switzerland, UAE and USA